OBJECTIVE: We sought to comparatively assess cardiac magnetic resonance imaging (CMRI) myocardial perfusion reserve index (MPRI) in women with confirmed microvascular coronary dysfunction (MCD) cases and reference control women. BACKGROUND: Women with signs or symptoms of myocardial ischemia in the absence of obstructive coronary artery disease (CAD) frequently have MCD which carries an adverse prognosis. Diagnosis involves invasive coronary reactivity testing (CRT). Adenosine CMRI is a non-invasive test that may be useful for the detection of MCD. METHODS: Fifty-three women with MCD confirmed by CRT and 12 age- and estrogen-use matched reference controls underwent adenosine CMRI. CMRI was assessed for MPRI, calculated using the ratio of myocardial blood flow at hyperemia/rest for the whole myocardium and separately for the 16 segments as defined by the American Heart Association. Statistical analysis was performed using repeated measures ANOVA models. RESULTS: Compared to reference controls, MCD cases had lower MPRI values globally and in subendocardial and subepicardial regions (1.63±0.39 vs. 1.98±0.38, P=0.007, 1.51±0.35 vs. 1.84±0.34, P=0.0045, 1.68±0.38 vs. 2.04±0.41, P=0.005, respectively). A perfusion gradient across the myocardium with lower MPRI in the subendocardium compared to the subepicardium was observed for both groups. CONCLUSIONS: Women with MCD have lower MPRI measured by perfusion CMRI compared to reference controls. CMRI may be a useful diagnostic modality for MCD. Prospective validation of a diagnostic threshold for MPRI in patients with MCD is needed.
OBJECTIVE: We sought to comparatively assess cardiac magnetic resonance imaging (CMRI) myocardial perfusion reserve index (MPRI) in women with confirmed microvascular coronary dysfunction (MCD) cases and reference control women. BACKGROUND:Women with signs or symptoms of myocardial ischemia in the absence of obstructive coronary artery disease (CAD) frequently have MCD which carries an adverse prognosis. Diagnosis involves invasive coronary reactivity testing (CRT). Adenosine CMRI is a non-invasive test that may be useful for the detection of MCD. METHODS: Fifty-three women with MCD confirmed by CRT and 12 age- and estrogen-use matched reference controls underwent adenosine CMRI. CMRI was assessed for MPRI, calculated using the ratio of myocardial blood flow at hyperemia/rest for the whole myocardium and separately for the 16 segments as defined by the American Heart Association. Statistical analysis was performed using repeated measures ANOVA models. RESULTS: Compared to reference controls, MCD cases had lower MPRI values globally and in subendocardial and subepicardial regions (1.63±0.39 vs. 1.98±0.38, P=0.007, 1.51±0.35 vs. 1.84±0.34, P=0.0045, 1.68±0.38 vs. 2.04±0.41, P=0.005, respectively). A perfusion gradient across the myocardium with lower MPRI in the subendocardium compared to the subepicardium was observed for both groups. CONCLUSIONS:Women with MCD have lower MPRI measured by perfusion CMRI compared to reference controls. CMRI may be a useful diagnostic modality for MCD. Prospective validation of a diagnostic threshold for MPRI in patients with MCD is needed.
Authors: Mariko L Ishimori; Rebecca Martin; Daniel S Berman; Pavel Goykhman; Leslee J Shaw; Chrisandra Shufelt; Piotr J Slomka; Louise E J Thomson; Jay Schapira; Yuching Yang; Daniel J Wallace; Michael H Weisman; C Noel Bairey Merz Journal: JACC Cardiovasc Imaging Date: 2011-01
Authors: Gregory O von Mering; Christopher B Arant; Timothy R Wessel; Susan P McGorray; C Noel Bairey Merz; Barry L Sharaf; Karen M Smith; Marian B Olson; B Delia Johnson; George Sopko; Eileen Handberg; Carl J Pepine; Richard A Kerensky Journal: Circulation Date: 2004-02-17 Impact factor: 29.690
Authors: B Delia Johnson; Leslee J Shaw; Steven D Buchthal; C Noel Bairey Merz; Hee-Won Kim; Katherine N Scott; Mark Doyle; Marian B Olson; Carl J Pepine; Jan den Hollander; Barry Sharaf; William J Rogers; Sunil Mankad; John R Forder; Sheryl F Kelsey; Gerald M Pohost Journal: Circulation Date: 2004-06-14 Impact factor: 29.690
Authors: Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell Journal: N Engl J Med Date: 2002-06-20 Impact factor: 91.245
Authors: Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane A Vido-Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Douglas Mc Nair; Robert W Biederman Journal: Cardiovasc Diagn Ther Date: 2013-12
Authors: Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane V Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Robert W W Biederman Journal: Cardiovasc Diagn Ther Date: 2016-10
Authors: Megha Agarwal; Chrisandra Shufelt; Puja K Mehta; Edward Gill; Daniel S Berman; Debiao Li; Behzad Sharif; Ning Li; C Noel Bairey Merz; Louise E J Thomson Journal: Cardiovasc Diagn Ther Date: 2013-09
Authors: May Bakir; Janet Wei; Michael D Nelson; Puja K Mehta; Afsaneh Haftbaradaran; Erika Jones; Edward Gill; Behzad Sharif; Piotr J Slomka; Debiao Li; Chrisandra L Shufelt; Margo Minissian; Daniel S Berman; C Noel Bairey Merz; Louise E J Thomson Journal: Cardiovasc Diagn Ther Date: 2016-02